Valentis
🇱🇹Lithuania
- Country
- 🇱🇹Lithuania
- Ownership
- Private
- Established
- 1919-01-01
- Employees
- 251
- Market Cap
- -
- Website
- https://www.valentis.com
Clinical Trials
2
Active:0
Completed:2
Trial Phases
1 Phases
Phase 2:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 2
2 (100.0%)Trial of VLTS-934 in Subjects With Intermittent Claudication Secondary to Peripheral Arterial Disease
Phase 2
Completed
- Conditions
- Peripheral Vascular Disease
- First Posted Date
- 2005-06-03
- Last Posted Date
- 2007-11-22
- Lead Sponsor
- Valentis
- Target Recruit Count
- 148
- Registration Number
- NCT00113009
- Locations
- 🇺🇸
University of Michigan Health Systems, Ann Arbor, Michigan, United States
Trial of VLTS-589 in Subjects With Intermittent Claudication
Phase 2
Completed
- Conditions
- Intermittent ClaudicationPeripheral Vascular Disease
- First Posted Date
- 2003-09-10
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- Valentis
- Target Recruit Count
- 100
- Registration Number
- NCT00068133
- Locations
- 🇺🇸
Cardiology Pc, Birmingham, Alabama, United States
🇺🇸Arizona Heart Institute, Phoenix, Arizona, United States
🇺🇸Access Clinical Trials-Cardiovascular Research, Beverly Hills, California, United States
News
No news found